骨周骨肉瘤:新兴的临床概念,不断发展的治疗选择:叙述性审查
Matthew B Bratton1, Humza A Pirzadah1, Michael J Starns1
1School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Current pain and headache reports
|December 15, 2025
概括
骨周骨类骨肉瘤是一种罕见的骨癌. 治疗策略尚未明确,但疼痛管理和像p53基因这样的分子标显示出未来研究的前景.
科学领域:
- 整形瘤学 整形瘤学
- 骨恶性瘤是一种恶性瘤.
- 骨瘤 骨瘤是指骨上的瘤.
背景情况:
- 骨周骨骨肉瘤是罕见的,占骨恶性瘤的<2%.
- 以前被认为会影响长骨隔膜,现在在关节骨,下和肩中发现.
- 关于最佳治疗策略的数据有限.
研究的目的:
- 综合有关骨周骨类骨肉瘤的当前数据.
- 检查临床,组织学和放射学表现.
- 调查潜在的生物标志物,并建议未来的研究方向.
主要方法:
- 文献综述和现有数据的综合.
- 对临床表现的分析,包括疼痛管理.
- 对分子发现和潜在的治疗点进行审查.
主要成果:
- 存活率和复发率受到脑髓侵袭的阶段,级别和程度的影响.
- 骨头疼痛是一种常见的症状,可以用阿片类药物和辅助药物来治疗.
- 发现了像p53基因这样的常见突变,这表明了未来的分子标.
结论:
- 需要进一步的研究来建立最佳的治疗方案.
- 生物标志物发现对于向治疗至关重要.
- 了解分子变化可能会指导未来的骨周骨髓骨肉瘤管理.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Barrett Esophagus-II: Clinical Manifestations and Management
738
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
738
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K


